Erratum: Disregulated glyceroneogenesis, PCK1 as a candidate diabetes and obesity gene (Trends in Endocrinology and Metabolism (2004) 15:3 (129-135) DOI: 10.1016/j.tem.2004.02.006;Disregulated glyceroneogenesis: PCK1 as a candidate diabetes and obesity gene

Trends in Endocrinology and Metabolism

Volumn 15, Issue 3, 2004, Pages 129-135

  Beale, Elmus G ^a   Hammer, Robert E ^b   Antoine, Bénédicte ^c   Forest, Claude ^c  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; GLUCOSE; GLYCEROPHOSPHATE; INSULIN; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); TRIACYLGLYCEROL;

ADIPOCYTE; ADIPOSE TISSUE; DIET; DISEASE ASSOCIATION; FEEDING; GENE; GENE EXPRESSION; GENE LOCUS; GENE MUTATION; GENETIC CODE; GENETIC PREDISPOSITION; GENETIC TRANSCRIPTION; GLUCONEOGENESIS; GLYCERONEOGENESIS; HUMAN; HYPOTHESIS; INSULIN RESISTANCE; LIPID STORAGE; LIPODYSTROPHY; LIPOLYSIS; LIVER; METABOLISM; MUTATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OXIDATION; PCK 1 GENE; PHENOTYPE; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SYNTHESIS;

EID: 1842523229     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tem.2004.05.006     Document Type: Erratum

References (45)

1. Permutt M.A., Hattersley A.T. Searching for type 2 diabetes genes in the post-genome era. Trends Endocrinol. Metab. 11:2000;383-393.
2. Elbein S.C. Perspective: the search for genes for type 2 diabetes in the post-genome era. Endocrinology. 143:2002;2012-2018.
3. Ghosh S., et al. Type 2 diabetes: evidence for linkage on chromosome 20 in 716 Finnish affected sib pairs. Proc. Natl. Acad. Sci. U. S. A. 96:1999;2198-2203.
4. Zouali H., et al. A susceptibility locus for early-onset non-insulin dependent (type 2) diabetes mellitus maps to chromosome 20q, proximal to the phosphoenolpyruvate carboxykinase gene. Hum. Mol. Genet. 6:1997;1401-1408.
5. Tilghman S.M., et al. Hormonal regulation of phosphoenolpyruvate carboxykinase (GTP) in mammalian tissues. Hanson R.W., Mehlman M.A. Gluconeogenesis: Its Regulation in Mammalian Species. 1976;47-91 John Wiley & Sons.
6. Hanson R.W., Reshef L. Regulation of phosphoenolpyruvate carboxykinase (GTP) gene expression. Annu. Rev. Biochem. 66:1997;581-611.
7. Vidnes J., Sovik O. Gluconeogenesis in infancy and childhood. III. Deficiency of the extramitochondrial form of hepatic phosphoenolpyruvate carboxykinase in a case of persistent neonatal hypoglycaemia. Acta Paediatr. Scand. 65:1976;307-312.
8. Reshef L., et al. Glyceroneogenesis and the triglyceride/fatty acid cycle. J. Biol. Chem. 278:2003;30413-30416.
9. Hanson, R.L. and Reshef, L. (2003) Glyceroneogenesis revisited. Biochimie (in press).
10. Owen O.E., et al. The key role of anaplerosis and cataplerosis for citric acid cycle function. J. Biol. Chem. 277:2002;30409-30412.
11. Ballard F.J., et al. Phosphoenolpyruvate carboxykinase and the synthesis of glyceride-glycerol from pyruvate in adipose tissue. J. Biol. Chem. 242:1967;2746-2750.
12. Gorin E., et al. Glyceroneogenesis in adipose tissue of fasted, diabetic and triamcinolone treated rats. Eur. J. Biochem. 8:1969;370-375.
13. Reshef L., et al. Glyceride-glycerol synthesis from pyruvate. Adaptive changes in phosphoenolpyruvate carboxykinase and pyruvate carboxylase in adipose tissue and liver. J. Biol. Chem. 244:1969;1994-2001.
14. Reshef L., et al. A possible physiological role for glyceroneogenesis in rat adipose tissue. J. Biol. Chem. 245:1970;5979-5984.
15. Beale E.G., et al. Regulation of cytosolic phosphoenolpyruvate carboxykinase gene expression in adipocytes. Biochimie. 85:2003;1207-1211.
16. Beale E.G., et al. Glyceroneogenesis comes of age. FASEB J. 16:2002;1695-1696.
17. Beale E.G., et al. Glyceroneogenesis in adipocytes: another textbook case. Trends Biochem. Sci. 28:2003;402-403.
18. Kalhan S.C., et al. Glyceroneogenesis and the source of glycerol for hepatic triacylglycerol synthesis in humans. J. Biol. Chem. 276:2001;12928- 12931.
19. Tordjman J., et al. Fatty acid recycling in adipocytes: a role for glyceroneogenesis and phosphoenolpyruvate carboxykinase. Biochem. Soc. Trans. 31:2003;1125-1129.
20. Forest, C. and Beale, E.G. New developments in nutrition and diabetes: glyceroneogenesis comes of age. Biochimie (in press).
21. Horowitz J.F. Fatty acid mobilization from adipose tissue during exercise. Trends Endocrinol. Metab. 14:2003;386-392.
22. Wolfe R.R., et al. Role of triglyceride-fatty acid cycle in controlling fat metabolism in humans during and after exercise. Am. J. Physiol. 258:1990;E382-E389.
23. Jensen M.D., et al. Lipid metabolism during fasting. Am. J. Physiol. Endocrinol. Metab. 281:2001;E789-E793.
24. McGarry J.D. What if Minkowski had been ageusic? An alternative angle on diabetes. Science. 258:1992;766-770.
25. McGarry J.D. Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes. 51:2002;7-18.
26. Unger R. Lipid overload and overflow: metabolic trauma and the metabolic syndrome. Trends Endocrinol. Metab. 14:2003;398-403.
27. Tordjman J., et al. Thiazolidinediones block fatty acid release by inducing glyceroneogenesis in fat cells. J. Biol. Chem. 278:2003;18785-18790.
28. Olswang Y., et al. A mutation in the peroxisome proliferator-activated receptor γ-binding site in the gene for the cytosolic form of phosphoenolpyruvate carboxykinase reduces adipose tissue size and fat content in mice. Proc. Natl. Acad. Sci. U. S. A. 99:2002;625-630.
29. Devine J.H., et al. Adipose expression of the phosphoenolpyruvate carboxykinase promoter requires peroxisome proliferator-activated receptor γ and 9-cis-retinoic acid receptor binding to an adipocyte-specific enhancer in vivo. J. Biol. Chem. 274:1999;13604-13612.
30. Aitman T.J. Genetic medicine and obesity. N. Engl. J. Med. 348:2003;2138-2139.
31. Franckhauser S., et al. Increased fatty acid re-esterification by PEPCK overexpression in adipose tissue leads to obesity without insulin resistance. Diabetes. 51:2002;624-630.
32. Lee J.H., et al. Genome scan for human obesity and linkage to markers in 20q13. Am. J. Hum. Genet. 64:1999;196-209.
33. Short M.K., et al. Tissue-specific, developmental, hormonal, and dietary regulation of rat phosphoenolpyruvate carboxykinase-human growth hormone fusion genes in transgenic mice. Mol. Cell. Biol. 12:1992;1007-1020.
34. Beale E.G., et al. Cell-specific expression of cytosolic phosphoenolpyruvate carboxykinase in transgenic mice. FASEB J. 6:1992;3330-3337.
35. Tontonoz P., et al. PPARγ2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene. Mol. Cell. Biol. 15:1995;351-357.
36. Glorian M., et al. A single element in the phosphoenolpyruvate carboxykinase gene mediates thiazolidinedione action specifically in adipocytes. Biochimie. 83:2001;933-943.
37. Spiegelman B.M. PPARγ adipogenic regulator and thiazolidinedione receptor. Diabetes. 47:1998;507-514.
38. Duplus E., et al. Expression of the phosphoenolpyruvate carboxykinase gene in human adipose tissue: induction by rosiglitazone and genetic analyses of the adipocyte-specific region of the promoter in type 2 diabetes. Biochimie. 85:2003;1257-1264.
39. Valera A., et al. Transgenic mice overexpressing phosphoenolpyruvate carboxykinase develop non-insulin-dependent diabetes mellitus. Proc. Natl. Acad. Sci. U. S. A. 91:1994;9151-9154.
40. Tordjman J., et al. Regulation of glyceroneogenesis and phosphoenolpyruvate carboxykinase by fatty acids, retinoic acids and thiazolidinediones: potential relevance to type 2 diabetes. Biochimie. 85:2003;1213-1218.
41. Forest C., et al. Fatty acid recycling in adipocytes: a role for glyceroneogenesis and phosphoenolpyruvate carboxykinase. Biochem. Soc. Trans. 31:2003;1125-1129.
42. Hod Y., et al. Differential expression of the genes for the mitochondrial and cytosolic forms of phosphoenolpyruvate carboxykinase. Ann. N. Y. Acad. Sci. 478:1986;31-45.
43. She P., et al. Phosphoenolpyruvate carboxykinase is necessary for the integration of hepatic energy metabolism. Mol. Cell. Biol. 20:2000;6508-6517.
44. Rajala M.W., Scherer P.E. Minireview: the adipocyte - at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology. 144:2003;3765-3773.
45. Mora S., Pessin J. An adipocentric view of signaling and intracellular trafficking. Diabetes Metab. Res. Rev. 18:2002;345-356.